维普期刊资源整合服务平台（V6.5）

26篇 您的检索式：作者名="PAPPOT H"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	显示文摘	Pappot H Hoyer-Hansen G Ronne E	1997	Eur J Cancer1997，33，：	1
2	Oestrogen receptor beta over expression in males with non -small cell lung cancer is asso- ciated with better survival 显示文摘	Skov BG BM Fischer H Pappot	2008	Lung Cancer2008，59，1：	1
3	Presence of urokinase plasminogen activator,its inhibitor and receptor in small cell lung cancer and non-small cell lung cancer显示文摘	Pappot H Pfeiffer P Grondahlhansen J		0，，01：	1
4	Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival显示文摘	Skov BG Fischer BM Pappot H	2008	Lung Cancer2008，59，1：	1
5	The complex between urokinase (uPA) and its type-1 inhibitor (PAI-1) in pulmonary adenocarcinoma: relation to prognosis显示文摘	PAPPOT H PEDERSEN A N BRUNNER N	2006	Lung Cancer2006，51，2：	1
6	The complex be- tween urokinase(uPA) and its type-1 inhibitor ( PAI-1 ) in pulmonary adenocarcinoma : relation to prognosis显示文摘	Pappot H Pederson AN Brunner N	2006	Lung Cancer2006，51，2：	1
7	Vascular endothelialgrowth factor A and vascular endothelial growth factor receptor 2expression in non - small cell lung cancer patients : relation toprognosis显示文摘	Bonnesen B Pappot H Holmstav J	2009	Lung Cancer2009，66，3：	1
8	The receptor for urokinase plasmino-gen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal haemoglobinuria显示文摘	Ronne E Pappot H Grondahl-Hansen J	1995	Br J Haematol1995，89，3：	1
9	The complex between urokinase (uPA) and its type-1 inhibitor (PAI- 1) in pulmonary adenocarcinoma: relation to prognosis 显示文摘	Pappot H Pedersen AN Brunner N	2006	Lung Cancer2006，51，：	1
10	Levels of plasminogen activator inhibitor type 1 and urokinase plasminogen activator receptor in non-small cell lung cancer as measured by quantitative ELISA and semiquantitative immunohistochemistry显示文摘	Pappot H Skov BG Pyke C	1997	Lung Cancer1997，17，23：	1
11	Oestrogen receptor beta over ex-pression in males with non - small cell lung cancer is associatedwith better survival显示文摘	Skov BG BM Fischer H Pappot	2008	Lung Cancer2008，59，1：	1
12	The liberated domain I of urokinase plasminogen activator receptor--a new tumour marker in small cell lung cancer显示文摘	Almasi CE Drivsholm L Pappot H	2013	APMIS2013，121，3：	1
13	The complex between urokinase (uPA) and its type-1 inhibitor (PAI-l) in pulmonary adenocareinoma:relation toprognosis显示文摘	Pedersen AN Brunner N	2006	Lung Cancer2006，51，2：	1
14	Biomarkers in tissue from patients with upper gastrointestinal cancers treated with erlotinib and bevacizumab显示文摘	ROHRBERG K S PAPPOT H LASSEN U	2011	Cancer Biol Ther2011，11，8：	1
15	The complex between urokinase(uPA)and its type-1 inhibitor(PAI-1)in pulmonary adenocarcinoma:relation to prognosis显示文摘	Pappot H Pedersen A N Brunner N	2006	Lung Cancer2006，51，2：	1
16	Levels of plasminogen activator inhibitor type 1 and urokinase plasminogen activator receptor in non-small cell lung cancer as measured by quantitative ELISA and semiquantitative immunohistochemistry显示文摘	Pappot H Stov B G Pyke C	1997	Lung Cancer1997，17，23：	1
17	The receptor for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal haemoglobinuria显示文摘	Ronne E Pappot H Grondahl-Hansen J	1995	Br J haematol1995，89，3：	1
18	Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival显示文摘	Skov BG Fischer BM Pappot H	2008	Lung Cancer2008，59，1：	1
19	Estrogen receptor beta overexpression in males with non-small cell lung cancer is associated with better survival显示文摘	Skov B G Fischer B M Pappot H		0，，01：	1
20	The complex between urokinase (uPA) and its type - 1 inhibitor ( PAl - 1 ) in pulmo- nary adenocarcinoma: relation to prognosis 显示文摘	Pappot H Pedersen AN Brunner N et 81	2006	Lung Cancer2006，51，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示